Welcome to our dedicated page for TAT TECHNOLOGIES SEC filings (Ticker: TATT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on TAT TECHNOLOGIES's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into TAT TECHNOLOGIES's regulatory disclosures and financial reporting.
TAT Technologies Chief Operating Officer Jason Lewandowski completed a same-day option exercise and share sale involving 3,125 Ordinary Shares. He exercised 3,125 fully vested stock options at an exercise price of $6.59 per share and immediately sold all 3,125 shares at $41.14 per share in an open-market transaction, retaining no shares from the exercise.
According to the disclosure, this generated approximate gross proceeds of $107,965 for the reporting person before taxes and commissions. Following these transactions, he no longer holds these shares but continues to hold 6,250 unvested stock options that are scheduled to vest in two equal installments of 3,125 options on September 1, 2026, and December 1, 2026, subject to continued employment with the company.
TAT Technologies Ltd. filing under Rule 144 reports proposed resale of 3,125 Ordinary Shares; the filing lists Nasdaq as the trading market and an effective date of 06/01/2026. The disclosure also shows 3,125 Ordinary Shares sold in the prior three months on 05/26/2026 by Jason Lewandowski, and references 43,750 SARs granted on 12/01/2023 with No cash consideration (Stock received upon exercise of SAR).
TAT Technologies Ltd Chief Operating Officer Jason Lewandowski completed a same-day stock option exercise and sale involving 3,125 Ordinary Shares. He exercised 3,125 fully vested stock options at an exercise price of $6.59 per share and immediately sold all 3,125 shares in an open-market transaction at $39.22 per share. Footnotes state that no shares were retained from this transaction and approximate pre-tax net proceeds were $101,966, reflecting the spread between the sale and exercise prices. Following these transactions, he holds 9,375 unvested options that are scheduled to vest in three installments of 3,125 options on June 1, 2026, September 1, 2026, and December 1, 2026, subject to his continued employment with the company.
TAT Technologies Ltd. filed a Rule 144 notice reporting the proposed sale of 40,625 ordinary shares tied to stock appreciation rights exercised on 12/01/2023. The filing lists Oppenheimer & Co. Inc. as the broker. The shares were received no cash consideration upon exercise of SARs.
TAT Technologies reported first quarter 2026 revenue of $41.1 million, slightly below $42.1 million a year earlier, mainly due to supply chain disruptions and delays from certain OEM suppliers that constrained deliveries.
Net income was $3.4 million, down from $3.8 million, with basic earnings per share of $0.26 versus $0.35. Despite this, demand remained very strong and the value of long-term agreements and backlog reached an all-time high of about $580 million at the end of the quarter.
Cash and cash equivalents were $51.2 million and total assets were $232.8 million as of March 31, 2026. Adjusted EBITDA came to $4.9 million, compared with $5.7 million in the prior-year quarter. Management expects supply chain issues to be resolved in the next few months and anticipates growth resuming later in 2026.
TAT Technologies reported Q1 2026 revenue of $41.1 million, down slightly from $42.1 million a year earlier, as strength in OEM heat transfer and jet engine coating was offset by softer MRO activity due to supply chain disruptions. Gross profit edged up to $10.0 million, but higher research, selling, and administrative expenses lifted operating costs, reducing operating income to $3.0 million from $4.2 million.
Net income was $3.4 million, compared with $3.8 million in Q1 2025, with diluted earnings per share of $0.26 versus $0.34. Operating cash flow improved sharply to an inflow of $2.0 million from an outflow of $5.0 million, supported by lower receivables and higher payables, while inventory increased as the company buffered against supply chain and inflation pressures.
Cash and cash equivalents remained strong at $51.2 million as of March 31, 2026, and total assets were $232.8 million against liabilities of $52.3 million. Management highlights ongoing geopolitical risks around Israel but notes operations and results have not been materially affected to date. TAT also expects $4.3–$4.5 million of cash proceeds and a $4.1–$4.3 million gain from a pending sale of its minority stake in First Aviation Services, subject to closing.
TAT Technologies Ltd. furnishes an investor presentation on its first quarter of 2026, focusing on aviation maintenance, repair and overhaul, thermal solutions, APU services and landing gear MRO.
The company notes a trusted base of 300+ customers, a Q1 2026 backlog and long‑term agreements valued at about $580M, and participation in an APU market estimated at over $2B. It highlights positive cash flow from operations, an upward trend in revenue, strong balance sheet flexibility, and use of non‑U.S. GAAP measures such as Adjusted EBITDA and Adjusted EBITDA Margin.
TAT Technologies Ltd. Schedule 13G/A amendment discloses beneficial ownership by Phoenix Financial Ltd. and affiliated partnerships, reporting shared voting and dispositive power over specified ordinary shares.
The filing lists 1,142,490.67 shares (representing 8.8%) attributed to Phoenix Financial Ltd. and 810,779 shares (representing 6.24%) attributed to Partnership for Israeli shares, using May 4, 2026 as the outstanding-share anchor (12,983,137 ordinary shares outstanding).
TAT Technologies Ltd. Schedule 13G: IBI Investment House Ltd. reports beneficial ownership of 696,327 ordinary shares (representing 5.4% of the class) as of April 29, 2026. The filing states that IBI Mutual Funds Ltd. holds 656,327 shares (5.1%) and IBI I.B.I RE'EM GLOBAL, LP holds 40,000 shares (0.3%). The report notes the Subsidiaries manage funds independently and disclaims formation of a Section 13(d) group.
Meitav Investment House Ltd filed an amendment to a Schedule 13G/A reporting beneficial ownership positions in TAT Technologies Ltd ordinary shares as of April 27, 2026. The filing shows a largest reported shared holding of 2,206,907 shares (reported as 16.99%) by consolidated subsidiaries.
The disclosure breaks out holdings by related entities: MEITAV PROVIDENT FUNDS & PENSION LTD holds 1,035,302 shares (7.97%), MEITAV PORTFOLIO MANAGEMENT LTD holds 987,907 shares (7.61%), and a mutual-fund affiliate holds 183,698 shares (1.41%). The filing states each subsidiary operates under independent management and disclaims group formation and beneficial ownership beyond pecuniary interest.